CROI 2020 Program and Conference Information

Oral Sessions

Oral Abstract O-03 THERAPEUTIC INTERVENTIONS FOR HIV TREATMENT AND ERADICATION Auditorium Oral Abstract Moderators María J. Buzón , Vall d'Hebrón Research Institute, Barcelona Aadia Rana , University of Alabama, Birmingham, AL, USA 34 CABOTEGRAVIR+RILPIVIRINE EVERY 2MONTHS IS NONINFERIOR TOMONTHLY: ATLAS-2MSTUDY Edgar T. Overton , Gary J. Richmond, Giuliano Rizzardini, Hans Jaeger, Catherine Orrell, Firaya Nagimova, Fritz Bredeek, Miguel García-Deltoro, Paul D. Benn, Yuanyuan Wang, Krischan J. Hudson, David A. Margolis, Kimberly Smith, Peter E. Williams, William Spreen 35 PROSPECTIVE ENHANCEDMONITORING OF DOLUTEGRAVIR- BASED FIRST LINE INMALAWI Elvis Temfack , Andreas Jahn, Thokozani Kalua, Joseph Bitilinyu-Bangoh, Rose Nyirenda, Anne-Geneviève Marcelin, Vincent Calvez, Diane Descamps, Gilles Peytavin, Sarala Nicholas, David Maman, Sofie Spiers, Elisabeth Poulet, Elisabeth Szumilin, Birgitt Schramm 36 RANDOMIZED SWITCH TO B/F/TAF IN AFRICAN AMERICAN ADULTSWITHHIV 10:15 10:00 10:30 10:00 AM - 12:00 PM Debbie P. Hagins , Princy N. Kumar, Michael Saag, Anson K. Wurapa, Indira Brar, Daniel S. Berger, Olayemi Osiyemi, Corrilynn O. Hileman, Moti Ramgopal, Cheryl McDonald, Christiana Blair, Kristen Andreatta, Sean E. Collins, Diana Brainard, Hal Martin IMPACT OF ANTI-PD-1 AND ANTI-CTLA-4 ON THE HIV RESERVOIR INVIVO: THE AMC-095 STUDY Rachel L. Rutishauser, Danielle Rigau, Shelly Lensing, Sonia Bakkour, Michael P. Busch, Dirk Dittmer, Steven G. Deeks, Christine Durand, Sharon R. Lewin 38 A RANDOMIZED TRIAL OF THE IMPACT OF 3BNC117 AND ROMIDEPSIN ON THE HIV-1 RESERVOIR Henning Gruell, Yehuda Z. Cohen, Jesper D. Gunst, Marie H. Pahus, Clara Lehmann, Katrina Millard, Martin Tolstrup, Julio C. Lorenzi, Michel Nussenzweig, Gerd Fätkenheuer, Florian Klein, Marina Caskey, Ole S. Søgaard 39 SAFETY &PHARMACOKINETICS OF GS-9722 INHIV-NEGATIVE PARTICIPANTS AND PEOPLEWITHHIV Peter Ruane , Eric Daar, Kimberly Workowski, Rebecca Begley, Rita Humeniuk, Tariro Makadzange, Steve K. West, Hui Liu, Yizhao Li, John Ling, Luisa M. Stamm, Polina German, Joseph J. Eron, Princy N. Kumar, Edwin DeJesus 40 SAFETY AND ANALYTIC TREATMENT INTERRUPTION OUTCOMES OF VESATOLIMOD INHIV CONTROLLERS Devi Sengupta , Moti Ramgopal, Cynthia Brinson, Edwin DeJesus, Anthony Mills, Peter Shalit, Scott McCallister, Hiba Graham, Heena Patel, Lijie Zhong, Joseph Hesselgesser, Brian Doehle, Susan Guo, Diana Brainard, Steven G. Deeks 37 Thomas A. Rasmussen , Laskhmi Rajdev, Ajantha Solomon, Ashanti Dantanarayana, Surekha Tennakoon, Socheata Chea, 10:45 11:00 11:15 11:30

Oral Sessions • Monday

CROI 2020 36